Roelof Botha sold $17M of NTRA
director at Natera, Inc.. 78,000 shares at an average of $220.31, traded Jun 1, 2026, filed Jun 3, 2026.
Score components
- +15RoleDirector
- +25Trade size$17.2M at market
- 0Share of holdings soldSold 6.8% of holdings
- +15Cluster7 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001222287-26-000011, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jun 1, 2026 | SOpen-market sale Common Stockindirect: Estate planning vehicles | -26,411 | $218.69 | $5.8M | 1,127,787 | Jun 3, 2026 |
| Jun 1, 2026 | SOpen-market sale Common Stockindirect: Estate planning vehicles | -10,100 | $219.78 | $2.2M | 1,117,687 | Jun 3, 2026 |
| Jun 1, 2026 | SOpen-market sale Common Stockindirect: Estate planning vehicles | -21,304 | $220.94 | $4.7M | 1,096,383 | Jun 3, 2026 |
| Jun 1, 2026 | SOpen-market sale Common Stockindirect: Estate planning vehicles | -14,885 | $221.58 | $3.3M | 1,081,498 | Jun 3, 2026 |
| Jun 1, 2026 | SOpen-market sale Common Stockindirect: Estate planning vehicles | -2,850 | $222.79 | $635k | 1,078,648 | Jun 3, 2026 |
| Jun 1, 2026 | SOpen-market sale Common Stockindirect: Estate planning vehicles | -2,450 | $223.83 | $548k | 1,076,198 | Jun 3, 2026 |
Related signals
Other insiders at Natera, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 38Weak | Natera, Inc. | Steven Leonard Chapman CEO AND PRESIDENT | $526k 1,273 shares | -1% | |
| 40Moderate | Natera, Inc. | Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS | $1.2M 3,000 shares | -3% | |
| 55Moderate | Natera, Inc. | Jonathan Sheena director, other | $7.0M 18,064 shares | -100% | |
| 35Weak | Natera, Inc. | Jonathan Sheena director, other | $3.2M 9,150 shares | -4% | |
| 40Moderate | Natera, Inc. | Matthew Rabinowitz EXECUTIVE CHAIRMAN | $35M 102,000 shares | -5% | |
| 40Moderate | Natera, Inc. | Matthew Rabinowitz EXECUTIVE CHAIRMAN | $16M 50,000 shares | -2% | |
| 39Weak | Natera, Inc. | Steven Leonard Chapman CEO AND PRESIDENT | $545k 1,698 shares | -2% | |
| 45Moderate | Natera, Inc. | Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS | $5.9M 18,160 shares | -14% | |
| 40Moderate | Natera, Inc. | John Fesko PRESIDENT, CHIEF BUS. OFFICER | $2.1M 6,517 shares | -3% | |
| 35Weak | Natera, Inc. | Jonathan Sheena director, other | $2.0M 6,000 shares | -3% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.